Vir Biotechnology

Vir Biotechnology is a biotechnology company that develops medicines to fight infectious diseases, including viruses like COVID-19 and hepatitis B. They focus on understanding how viruses infect people and creating treatments, such as monoclonal antibodies, that can neutralize these viruses. Their goal is to improve health outcomes by offering innovative therapies that complement vaccines and existing medicines. By combining advanced scientific research with cutting-edge technology, Vir Biotechnology aims to provide effective solutions to prevent and treat serious infectious diseases worldwide.